A key committee reviewing India’s drug pricing reforms has been expanded to include patients, shifting the debate from numbers on paper to real healthcare impact. The move aims to make pricing decisions more grounded in affordability and access, potentially influencing how reforms are designed and implemented as stakeholders push for faster, fairer outcomes.
India’s hospitals and health insurers are locked in a tariff and cashless settlement standoff, with patients stuck between refusals and stalled claims. Disputes ranging from AHPI’s clash with Star Health to insurers suspending ties with Max Hospitals point to a strained system where rising treatment costs meet stagnant payouts and there’s no decisive regulator to arbitrate.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
